The $2 Insulin and the $300 Vial

Framework walkthrough

1. Why is insulin expensive? Not because the molecule is hard to make — it is one of the simpler biologics. Not because of ongoing research costs — the basic drug is over a century old. The high price comes from a stack of state-imposed structures: approval pathways that make new entrants prohibitively expensive to certify, biosimilar approval rules that slow generics to a trickle, prescription requirements that exclude direct purchase, import bans that block cheaper foreign supply, and a market consolidated to three suppliers who have no strong incentive to cut each other's margins.
2. Each of these structures is a coercion-backed barrier — they exist because the state forbids the exchanges that would route around them. A small manufacturer who could produce insulin at low cost cannot legally sell it without billions in state certification costs. A patient cannot legally import the same drug from a country where it sells for a fraction of the price. A diabetes patient cannot legally buy direct from a manufacturer. Each prohibition is force preventing a voluntary exchange.
3. Is the scarcity of cheap insulin natural? The dictionary on scarcity: 'the condition where resources, time, or attention are limited in supply.' Natural scarcity is what physics imposes — insulin requires actual molecules, energy, equipment. Institutional scarcity is what laws and state-enforced prohibitions impose — barriers to production, distribution, or exchange that exist by political choice rather than physical necessity.
4. The diabetic rationing doses is dealing with institutional scarcity. The molecule exists. The capacity to make it exists. The willingness to sell at low cost exists somewhere on earth. What does not exist is the legal permission to connect supply to demand without paying a toll to incumbents and state-licensed certifiers.
5. Who are the victims? Every diabetic priced out, every patient who rationed and crashed, every family that chose between insulin and rent. Their harm is not produced by the drug or by physics — it is produced by the state-imposed structures around the exchange. The structures have agents: legislators, state officials, lobbyists. The responsibility for the deaths follows the causation chain backward through every barrier maintained against voluntary exchange.
6. What is the civilizational velocity cost? Enormous. Every dollar spent overpaying for an old drug is a dollar not spent on new treatments. Every patient who dies for lack of access is a person who could have lived and contributed to the next round of knowledge. The institutional layer between supply and demand is a velocity tax — paid in lives.
7. Defenders of the structure argue that without these barriers there would be unsafe drugs, fraud, public health catastrophe. The framework's response: rules that enforce honesty (disclosure of contents, accuracy of labels, prosecution of fraud) are different in kind from rules that block voluntary exchange. The first support consent; the second override it. Disclosure rules are velocity-positive. Permission rules — beyond disclosure — are velocity-negative.